- Markets
- ToolsPortfoliosTrack performance, allocation, dividends, and risksStock screenerFilter, compare, and track stocksInsiders tradingSee how executives tradeHistogramSee ratios across industriesSaved screenersMy highlights
- Sign in
- Sign up for free
- 1
- Portfolios
- Tools
- Stock screener
- Cryptocurrency screener
- Insiders trading
- SEC filings
- Bubbles
- Histogram
- Markets
Sign inSign up for free
| Market cap | $4.87B |
|---|---|
| Enterprise value | $8.63B |
| Revenue | $743.250M |
|---|---|
| EBITDA | $9.038M |
| Income | -$351.94 |
| Revenue Q/Q | 29.36% |
| Revenue Y/Y | 24.65% |
| P/E | N/A |
|---|---|
| Forward P/E | 158.73 |
| EV/Sales | 11.61 |
| EV/EBITDA | 955.04 |
| EV/EBIT | N/A |
| PEG | N/A |
| Price/Sales | 6.56 |
| P/FCF | N/A |
| Price/Book | 1.46 |
| Book/Share | 3.00 |
| Cash/Share | 0.40 |
| FCF yield | -1.03% |
| Employees | 1,200 |
|---|---|
| RPE | $619.375k |
| Volume | 15.999M/15.549M |
|---|---|
| Relative vol. | 1.03 × |
| EPS | -0.32 |
|---|---|
| EPS Q/Q | N/A |
| Est. EPS Q/Q | N/A |
| Profit margin | -231.64% |
|---|---|
| Oper. margin | -15.41% |
| Gross margin | 24.15% |
| EBIT margin | -9.24% |
| EBITDA margin | 1.22% |
| Ret. on assets | -8.16% |
|---|---|
| Ret. on equity | -10.45% |
| ROIC | 0.12% |
| ROCE | 0.00% |
| Debt/Equity | 0.29 |
|---|---|
| Net debt/EBITDA | 79.43 |
| Current ratio | 1.92 |
| Quick ratio | 1.18 |
| Volatility | 49.34% |
|---|---|
| Beta | 2.62 |
| RSI | 19.23 |
|---|
| Range | $4.39 – $4.39 |
|---|---|
| 52 weeks | $4.39 – $4.39 |
| SMA 50 | $18 -301.60% |
| SMA 200 | $17 -298.40% |
| 1 year target | N/A |
|---|---|
| Mean Recomm. | N/A |
| Insider ownership | 0.11% |
|---|---|
| Inst. ownership | 19.08% |
| Shares outst. | 316.795M |
|---|---|
| Shares float | 311.226M 98.24% |
| Short % of float | N/A |
| Short ratio | 1.91 |
| 1 year target | N/A |
|---|---|
| Mean Recomm. | N/A |
| Dividend | N/A |
|---|---|
| Dividend yield | N/A |
| Payout ratio | N/A |
| Payment date | N/A |
| Ex-dividend date | N/A |
| Earnings date | N/A |
| IPO year | 2020 |
|---|---|
| Country | Canada |
| Compare with other stocks |
|---|
Intraday
5 days
1 month
3 months
6 months
1 year
5 years
N/A
All time
- Overview
- Real-time
Recent Aphria news
Filter
Tuesday, 11 May 2021 | |
fool | What's Next for Tilray Now That Its Merger With Aphria Is Complete? |
fool | 3 Robinhood Stocks Investors Can't Get Enough Of |
Monday, 10 May 2021 | |
yahoo | Tilray, Inc. Reports Q1 Loss, Misses Revenue Estimates |
Saturday, 8 May 2021 | |
fool | Why Tilray Stock Dropped in April |
Friday, 7 May 2021 | |
fool | Here's Why Tilray Stock Is Surging |
fool | Tilray, Datadog Give Nasdaq Investors Something to Smile About |
fool | Why OrganiGram Holdings Stock Jumped Today |
fool | Why Canopy Growth, Aurora Cannabis, and HEXO Stocks Are Glowing Green Today |
Tuesday, 4 May 2021 | |
fool | Can These 3 Promising Mid-Caps Grow Their Way Into Large-Caps? |
Monday, 3 May 2021 | |
fool | 3 Top Robinhood Stocks to Buy in May |
fool | The Aphria and Tilray Merger Finally Closes |
yahoo | Robinhood is a ‘misunderstood platform’: Kevin O'Leary |
marketwatch | Tilray and Aphria merger closes and creates world’s biggest weed company by revenue |
Sunday, 2 May 2021 | |
marketwatch | Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue |
Friday, 30 April 2021 | |
yahoo | Tilray-Aphria deal approved in cannabis mega-merger |
fool | Better Robinhood Stock: Ocugen or Aphria? |
Thursday, 29 April 2021 | |
yahoo | Good Supply Expands Product Portfolio With the Introduction of Hash, Wax, and Kief |
Wednesday, 28 April 2021 | |
fool | Why Aurora Cannabis, Hexo, and Aphria Stocks Are On Fire Today |
Friday, 23 April 2021 | |
fool | Why Aurora Cannabis, Hexo, and Aphria Stocks Ran Higher Today |
fool | 3 Extremely Undervalued Stocks to Buy Now |
Thursday, 22 April 2021 | |
fool | Aphria Inc. Q3 2021 Earnings Call Transcript |
Tuesday, 20 April 2021 | |
fool | Is the Aphria-Tilray Merger in Trouble? |
Monday, 19 April 2021 | |
fool | Why Aphria, OrganiGram Holdings, and Aurora Cannabis Rose Today |
yahoo | Here's how legal weed will play out in America |
Sunday, 18 April 2021 | |
yahoo | Aphria Shareholders Approve Tilray Merger |
Saturday, 17 April 2021 | |
yahoo | 10 Cheap Pharmaceutical Stocks For 2021 |
Friday, 16 April 2021 | |
barrons | Tilray Lowers the Bar for Merger With Aphria |
marketwatch | Aphria and Tilray cannabis merger moves a step closer to approval |
Thursday, 15 April 2021 | |
marketwatch | UPDATE: Aphria shareholders vote overwhelmingly in favor of proposed Tilray merger; Tilray vote moved to April 30 |
yahoo | Aphria Inc. Shareholders Overwhelmingly Approve Proposed Arrangement With Tilray, Inc. |
fool | 3 Warning Signs From Aphria's Abysmal Earnings Report |
fool | Is Tilray a Buy? |
fool | 3 Robinhood Stocks That Have More Than Doubled in 2021: Are They Buys Now? |
Tuesday, 13 April 2021 | |
yahoo | Aphria’s 3Q Sales and EPS Miss Estimates; Shares Plunge 14% |
fool | Forget Aphria and Tilray: This Cannabis Merger Is Much More Promising |
Monday, 12 April 2021 | |
fool | Why Canopy Growth, Aurora Cannabis, and Hexo Stocks Went Up in Smoke Today |
investors | Marijuana Stocks Fall As Aphria Earnings Set Tone For Tough Quarter |
fool | Here's Why Investors Hated Aphria's Q3 Results |
fool | Why Aphria and Tilray Stocks Are Tanking Today |
reuters | Pot producer Aphria posts quarterly loss as COVID-19 hits demand, shares slump |
yahoo | Aphria Inc. Reports Q3 Loss, Misses Revenue Estimates |
marketwatch | Aphria stock falls after wider-than-expected loss, revenue misses as COVID-19 reduced demand |
Friday, 9 April 2021 | |
yahoo | Why Virginia legalizing marijuana could be a catalyst for federal legalization |
fool | 3 Best Marijuana Stocks so Far This Year: Are They Buys Now? |
Thursday, 8 April 2021 | |
zacks | Aphria Inc. Outpaces Stock Market Gains: What You Should Know |
investors | Top Marijuana Stock Could Fill Key Void With Latest Buyout As Competition Increases |
zacks | New Strong Sell Stocks for April 8th |
fool | Should You Buy Tilray in April? |
Wednesday, 7 April 2021 | |
fool | Why Cannabis Stocks Aphria, Aurora Cannabis, Charlotte's Web, and Tilray Slid Today |
yahoo | /R E P E A T -- AMP Appoints National Sales Director and Launches Nationwide Marketing Sales Campaign for Branded Medical Cannabis Products in Germany/ |
yahoo | AMP Appoints National Sales Director and Launches Nationwide Marketing Sales Campaign for Branded Medical Cannabis Products in Germany |
Tuesday, 6 April 2021 | |
marketwatch | Aphria revenue estimates lowered by Stifel ahead of Q3 earnings on weak cannabis consumption trends |
Filter news
Notable SEC filings of Aphria Inc.
All filingsLast yearly filingFilter
Notable SEC filings of Aphria Inc.
All filingsLast yearly filingFilter
| 6-K 4 May 2021 | News Release dated May 3, 2021 | ||||
| 6-K29 Apr 2021 | News Release dated April 29, 2021 | ||||
| 6-K26 Apr 2021 | News Release dated April 26, 2021 | ||||
| 6-K26 Apr 2021 | Voting Results from November 17, 2020 Annual General and Special Meeting of Shareholders of Aphria Inc. | ||||
| 6-K15 Apr 2021 | News Release dated April 15, 2021 | ||||
| 6-K15 Apr 2021 | News Release dated April 15, 2021 | ||||
| 6-K12 Apr 2021 | News Release dated April 12, 2021 | ||||
| 6-K12 Apr 2021 | Condensed Interim Consolidated Financial Statements for the three and nine months ended February 28, 2021 | ||||
| 6-K 9 Apr 2021 | News Release dated April 9, 2021 | ||||
| 6-K 5 Apr 2021 | News Release dated April 5, 2021 | ||||
| 6-K31 Mar 2021 | News Release dated March 31, 2021 | ||||
All SEC filingsLast yearly filingFilter filings
210,712 people own Aphria on Robinhood
Powered byRobintrack.
Aphria executives
| Insider | Age | Since | Compensation |
|---|---|---|---|
| IrwinSimon(62)Chairman of the Board and Chief Executive Officersince 2019 | 62 | 2019 | $9,577,300 |
| JamesMeiers | 2019 | $2,938,320 | |
| DeniseFaltischek | 2019 | $2,270,700 | |
| ChristelleGedeon | 2018 | $1,607,980 | |
| CarlMerton | $1,374,440 | ||
| HendrikKnopp | $691,961 | ||
| RenahPersofsky(62)Independent Directorsince 2017 | 62 | 2017 | $423,877 |
| JohnHerhalt(63)Independent Directorsince 2019 | 63 | 2019 | $332,960 |
| ThomasLooney(57)Independent Directorsince 2018 | 57 | 2018 | $256,278 |
| JodiButts(48)Directorsince 2019 | 48 | 2019 | $158,152 |
| WalterRobb(66)Independent Directorsince 2019 | 66 | 2019 | $33,168 |
| DavidHopkinson(49)Independent Directorsince 2019 | 49 | 2019 | $33,168 |
| BernardYeung | 2019 | ||
| TamaraMacgregor | 2019 |
Aphria Inc.aphriainc.com
Aphria Inc.aphriainc.com
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
- Health Care>Pharmaceuticals
- Aphria Inc., 98 Talbot Street West, Leamington N8H 1M8, Canada
- 844 427 4742
- Investor relations
Profit margin
- Quarterly
- Annual
Debt to assets
- Quarterly
- Annual
Cash flow
- Quarterly
- Annual
- Quarterly
- Annual
XSLX
XSLX
| (in millions USD) | 29 Feb 2024 | 30 Nov 2023 | 31 Aug 2023 | 31 May 2023 | |
|---|---|---|---|---|---|
| Current assets | |||||
| Cash | $146.25 | $143.37 | $177.52 | $206.63 | |
| Short term investments | $79.6 | $116.42 | $287.33 | $241.9 | |
| Net receivables | $89.54 | $90.6 | $82.08 | $86.23 | |
| Inventory | $244.14 | $252.7 | $232.08 | $200.55 | |
| Other current assets | $28.64 | $2.31 | $5.31 | ||
| Total current assets | $631.21 | $642.03 | $829.26 | $773.03 | |
| Long term investments | $8.06 | $12.67 | $12.2 | $12.37 | |
| Property, plant & equipment | $596.24 | $628.64 | $500.22 | $435.61 | |
| Goodwill | $2,009.63 | $2,009.71 | $2,009.67 | $2,008.84 | |
| Intangible assets | $930.1 | $953.42 | $967.57 | $973.78 | |
| Other assets | $5.61 | $9.41 | $8.65 | $0.222 | |
| Deferred long term asset charges | |||||
| Total assets | $4,212.86 | $4,330.56 | $4,402.25 | $4,307.26 | |
| Current liabilities | |||||
| Accounts payable | $90.16 | $88.36 | $78.97 | $70.82 | |
| Short long term debt | $116.16 | $166.62 | $281.99 | $224.26 | |
| Other current liabilities | $4.62 | $14.72 | $32.92 | $32.97 | |
| Total current liabilities | $329.1 | $394.99 | $537.27 | $432.98 | |
| Long term debt | $347.91 | $348.8 | $273.25 | $357.93 | |
| Other liabilities | -$126.33 | -$179.71 | -$160.4 | -$157.33 | |
| Deferred long term liabilities | |||||
| Minority interest | -$15.82 | $25.02 | $22.18 | $14.25 | |
| Total liabilities | $869.82 | $937.2 | $1,000.69 | $977.32 | |
| Stockholders' equity | |||||
| Stock option warrants | |||||
| Common stock | $0.077 | $0.073 | $0.072 | $0.066 | |
| Retained earnings | -$2,628.74 | -$2,536.04 | -$2,487.03 | -$2,415.51 | |
| Treasury stock | |||||
| Capital surplus | |||||
| Other stockholder equity | -$59 | -$13.35 | -$21.38 | -$32.36 | |
| Total stockholder equity | $3,343.04 | $3,393.35 | $3,401.56 | $3,329.94 | |
| Net tangible assets | |||||
| (in millions USD) | 2023 | 2022 | |
|---|---|---|---|
| Current assets | |||
| Cash | $206.63 | $415.91 | |
| Short term investments | $241.9 | ||
| Net receivables | $86.23 | $95.28 | |
| Inventory | $200.55 | $245.53 | |
| Other current assets | |||
| Total current assets | $773.03 | $803.5 | |
| Long term investments | $12.37 | $15 | |
| Property, plant & equipment | $435.61 | $600.5 | |
| Goodwill | $2,008.84 | $2,641.3 | |
| Intangible assets | $973.78 | $1,277.88 | |
| Other assets | $0.222 | $0.314 | |
| Deferred long term asset charges | |||
| Total assets | $4,307.26 | $5,449.69 | |
| Current liabilities | |||
| Accounts payable | $70.82 | $68.6 | |
| Short long term debt | $224.26 | $92.65 | |
| Other current liabilities | $32.97 | $36.41 | |
| Total current liabilities | $432.98 | $280.34 | |
| Long term debt | $357.93 | $519.83 | |
| Other liabilities | -$157.33 | -$212.43 | |
| Deferred long term liabilities | |||
| Minority interest | $14.25 | $42.56 | |
| Total liabilities | $977.32 | $1,008.33 | |
| Stockholders' equity | |||
| Stock option warrants | |||
| Common stock | $0.066 | $0.053 | |
| Retained earnings | -$2,415.51 | -$962.85 | |
| Treasury stock | |||
| Capital surplus | |||
| Other stockholder equity | -$32.36 | $21.8 | |
| Total stockholder equity | $3,329.94 | $4,441.37 | |
| Net tangible assets | |||
Income statement
- Quarterly
- Annual
XSLX
XSLX
| (in millions USD) | 29 Feb 2024 | 30 Nov 2023 | 31 Aug 2023 | 31 May 2023 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Total revenue | $188.34 | $193.77 | $176.95 | $184.19 | |
| Cost of revenue | $136.7 | $141.66 | $127.65 | $115.77 | |
| Gross profit | $51.64 | $52.11 | $49.3 | $68.42 | |
| Operating activities | |||||
| Research & development | $0.106 | $0.056 | $0.079 | $0.18 | |
| Selling, general & administrative | $61.13 | $60.1 | $55.91 | $64.62 | |
| Non-recurring | |||||
| Other operating expenses | -$2.77 | -$1.01 | $1.27 | $37.18 | |
| Total operating expenses | $219.49 | $223.74 | $205.86 | $208.68 | |
| Operating income | -$31.15 | -$29.97 | -$28.91 | -$24.5 | |
| Income from continuing operations | |||||
| Net other income | -$2.77 | -$1.01 | $1.27 | $37.18 | |
| EBIT | |||||
| Interest expense | -$8.52 | -$8.62 | -$9.84 | -$38.05 | |
| Income before tax | -$107.85 | -$49.56 | -$48.6 | -$111.69 | |
| Income tax expense | -$2.87 | -$3.38 | $7.26 | $8.13 | |
| Minority interest | -$15.82 | $25.02 | $22.18 | $14.25 | |
| Net income from continuing ops | |||||
| Non-recurring events | |||||
| Discontinued operations | |||||
| Extraordinary items | |||||
| Effect of accounting change | |||||
| Other items | $76.67 | $19.14 | $19.8 | $86.85 | |
| Net income | |||||
| Net income | -$92.7 | -$64.67 | -$55.86 | -$138.71 | |
| Income (for common shares) | -$92.7 | -$64.67 | -$55.86 | -$138.71 | |
| (in millions USD) | 2023 | 2022 | |
|---|---|---|---|
| Revenue | |||
| Total revenue | $627.12 | $628.37 | |
| Cost of revenue | $475.68 | $509.34 | |
| Gross profit | $151.44 | $119.03 | |
| Operating activities | |||
| Research & development | $0.682 | $1.52 | |
| Selling, general & administrative | $230.94 | $232.69 | |
| Non-recurring | |||
| Other operating expenses | $16.45 | $0.279 | |
| Total operating expenses | $807.29 | $858.74 | |
| Operating income | -$180.16 | -$230.37 | |
| Income from continuing operations | |||
| Net other income | $16.45 | $0.279 | |
| EBIT | |||
| Interest expense | -$46.61 | -$39.68 | |
| Income before tax | -$1,450.18 | -$440.67 | |
| Income tax expense | -$7.18 | -$6.54 | |
| Minority interest | $14.25 | $42.56 | |
| Net income from continuing ops | |||
| Non-recurring events | |||
| Discontinued operations | |||
| Extraordinary items | |||
| Effect of accounting change | |||
| Other items | $1,272.21 | $217.04 | |
| Net income | |||
| Net income | -$1,452.66 | -$476.8 | |
| Income (for common shares) | -$1,452.66 | -$476.8 | |
- Quarterly
- Annual
XSLX
XSLX
| (in millions USD) | 29 Feb 2024 | 30 Nov 2023 | 31 Aug 2023 | 31 May 2023 | |
|---|---|---|---|---|---|
| Net income | -$111.19 | -$30.52 | -$71.52 | -$138.71 | |
| Operating activities | |||||
| Depreciation | $32.84 | $31.55 | $30.79 | $28.99 | |
| Net income adjustments | |||||
| Change in accounts receivable | |||||
| Changes in liabilities | |||||
| Changes in inventory | |||||
| Changes in other operating activities | |||||
| Total cash flows from operations | -$15.36 | -$30.41 | -$15.84 | $43.6 | |
| Investing activities | |||||
| Capital expenditures | -$9.53 | -$5.86 | -$4.15 | -$12.41 | |
| Investments | |||||
| Other cash flows from investing | $37.61 | $87.36 | -$22.14 | $4.82 | |
| Total cash flows from investing | $28.09 | $81.5 | -$26.29 | -$7.58 | |
| Financing activities | |||||
| Dividends paid | |||||
| Sale and purchase of stock | $2.64 | ||||
| Net borrowings | -$10.91 | -$85.37 | $14.02 | $6.24 | |
| Other cash flows from financing | -$2.64 | ||||
| Total cash flows from financing | -$10.91 | -$85.37 | $14.02 | $6.24 | |
| Effect of exchange rate | -$3.3 | -$1.02 | $6.27 | $1.09 | |
| Change in cash and equivalents | $1.3 | -$34.18 | -$27.5 | $41.64 | |
| (in millions USD) | 2023 | 2022 | |
|---|---|---|---|
| Net income | -$1,452.66 | -$476.8 | |
| Operating activities | |||
| Depreciation | $130.15 | $154.59 | |
| Net income adjustments | |||
| Change in accounts receivable | |||
| Changes in liabilities | |||
| Changes in inventory | |||
| Changes in other operating activities | |||
| Total cash flows from operations | $7.91 | -$177.26 | |
| Investing activities | |||
| Capital expenditures | -$20.8 | -$34.06 | |
| Investments | |||
| Other cash flows from investing | -$264.31 | $12.53 | |
| Total cash flows from investing | -$285.11 | -$21.53 | |
| Financing activities | |||
| Dividends paid | |||
| Sale and purchase of stock | $131.05 | $259.23 | |
| Net borrowings | -$58.25 | -$123.55 | |
| Other cash flows from financing | -$2.64 | -$7.48 | |
| Total cash flows from financing | $70.16 | $128.2 | |
| Effect of exchange rate | -$25.54 | -$28.38 | |
| Change in cash and equivalents | -$209.28 | -$72.56 | |
Sign up for free
This feature is available only for signed-in users.
Sign up
Already have an account?Sign in.
or
Sign up with GoogleSign up with Facebook
What symbols do you want to compare APHA with?
Please separate symbols by ','
Pardon the interruption.
You've browsed 3 companies this week,
let's make this official
Sign up
Already have an account? Sign in
or
Sign up with GoogleSign up with Facebook
"A killer stock screener."
— Berry M., Switzerland
Give wallmine a try – it's free.
